GUIDANCE DOCUMENT
CVM GFI #292 Chemistry, Manufacturing, and Controls Considerations for Type A Medicated Articles June 2024
Not for implementation. Contains non-binding recommendations.
This guidance is being distributed for comment purposes only.
Submit Comments by
Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment on a draft guidance before it begins work on the final version of the guidance, submit either online or written comments on the draft guidance before the close date.
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2024-D-1202
- Docket Number:
- FDA-2024-D-1202
- Issued by:
-
Guidance Issuing OfficeCenter for Veterinary Medicine
This guidance provides recommendations to sponsors submitting chemistry, manufacturing, and controls (CMC) information for Type A medicated articles. Type A medicated articles contain new animal drugs and provide for administration of these drugs in animal feed. Type A medicated articles are intended solely for use in the manufacture of another Type A medicated article or in the manufacture of a Type B or Type C medicated feed. Because Type A medicated articles are not directly administered to the animal, there are some issues specific to Type A medicated articles that do not apply to other new animal drug dosage forms. These unique considerations are highlighted in this guidance under the relevant Common Technical Document - Quality (CTD-Q) section headings.
Questions?
- Heather Longstaff
- Center for Veterinary Medicine
Food and Drug Administration
7500 Standish Place, HFV-147
Rockville, MD 20855
- Heather.Longstaff@fda.hhs.gov
- 240-402-0650